Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 1, 1997, Pages 64-69

  Bass, Hong Z ^a   Fahey, John L ^a   Nishanian, Parunag ^a   Detels, Roger ^b,c   Cumberland, William ^b   Kemeny, Margaret ^a   Plaeger, Susan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Los Angeles Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; NEOPTERIN;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031041479     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.1.64-69.1997     Document Type: Article

References (29)

1. Barak, M., D. Merzbach, and N. Gruener. The effect of immunomodulators on PHA or gamma-IFN induced release of neopterin from purified macrophages and peripheral blood mononuclear cells. Immunol. Lett. 21:317-322.
2. Bass, H. Z., W. D. Hardy, R. T. Mitsuyasu, J. M. Taylor, Y. X. Wang, M. A. Fischl, S. A. Spector, D. D. Richman, and J. L. Fahey. 1992. The effect of zidovudine treatment on serum neopterin and β2-microglobulin levels in midly symptomatic, HIV type 1 seropositive individuals. J. Acquired Immune Defic. Syndr. 5:215-221.
3. Bass, H. Z., P. Nishanian, W. D. Hardy, R. T. Mitsuyasu, E. Esmail, W. Cumberland, and J. L. Fahey. 1992. Significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin. Immunol. Immunopathol. 64:63-70.
4. Bass, H. Z., W. D. Hardy, R. T. Mitsuyasu, Y. X. Wang, W. Cumberland, and J. L. Fahey. 1992. Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J. Acquired Immune Defic. Syndr. 5:890-897.
5. Clerici, M., N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via, and G. M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1892-1899.
6. Detels, R., B. R. Visscher, J. L. Sever, M. Gavell, D. L. Madeen, K. Schwartz, J. P. Dudley, P. A. English, and H. Powers. 1987. Predictors of clinical AIDS in young homosexual men in a high-risk area. Int. J. Epidemiol. 16:271-276.
7. El-Sadr, W., M. Marmor, S. Zolla-Pazner, R. E. Stahl, R. Lyden, D. William, S. D'Onofrio, S. H. Weiss, and W. C. Saxinger. 1987. Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status and serology to human immunodeficiency virus. J. Infect. Dis. 155: 789-793.
8. Fahey, J. L., J. M. G. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322:166-172.
9. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151: 5031-5040.
10. Giorgi, J. V., P. G. Nishanian, I. Schmid, L. E. Hultin, H. L. Cheng, and R. Detels. 1987. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T lymphotropic virus type III/lymphadenopathy-associated virus) infection. J. Clin. Immunol. 7:140-150.
11. Giorgi, J. V., and R. Detels. 1989. T-cell subset alterations in HIV-infected homosexual men: NIAID MACS. Clin. Immunol. Immunopathol. 52:10-18.
12. Hofmann, B., B. O. Lindhardt, J. Gerstoft, C. S. Petersen, P. Platz, L. P. Ryder, N. Odum, E. Dickmeiss, P. B. Nielsen, and S. Ullman. 1987. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br. Med. J. 295:293-296.
13. Hofmann, B., I. Bygbjerg, E. Dickmeiss, V. Faber, B. Frederiksen, J. Gaub, J. Gerstoft, B. K. Jakobsen, K. D. Jakobsen, and B. O. Lindhardt. 1989. Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging. Scand. J. Infect. Dis. 21:633-643.
14. Hofmann, B., Y. X. Wang, W. C. Cumberland, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1990. Serum β2M level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 4:207-214.
15. Hofmann, B., H. Bass, P. Nishanian, M. Faisal, R. A. Figlin, G. P. Sarna, and J. L. Fahey. 1992. Different lymphoid cell populations produce varied levels of neopterin, β2M and sIL-2R when stimulated by IL2, IFN-gamma or TNF-alpha. Clin. Exp. Immunol. 88:548-554.
16. Hofmann, B., P. Nishanian, J. L. Fahey, I. Esmail, A. L. Jackson, R. Detels, and W. Cumberland. 1991. Serum increases and lymphoid cell surface losses of IL-2R CD25 in HIV infection: distinctive parameters of HIV-induced change. Clin. Immunol. Immunopathol. 61:212-224.
17. Hofmann, B., K. D. Jakobsen, N. Odum, E. Dickmeiss, P. Platz, L. P. Ryder, C. Persersen, L. Mathiesen, I. B. Bygbjerg, and V. Faber. 1989. The HIV-induced immunodeficiency: relatively preserved PHA as opposed to decreased PMM responses may be due to preserved responses via CD2/PHA pathway. J. Immunol. 142:1874-1880.
18. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo. 1987. The multicenter AIDS cohort study: rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
19. Lane, H. C., J. M. Depper, W. C. Geene, G. Whalen, T. A. Waldmann, and A. S. Fauci. 1985. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79-84.
20. Lane, H. C., H. Masur, E. P. Gelmann, D. L. Longo, R. G. Steis, T. Chused, G. Whalen, L. C. Edgar, and A. S. Fauci. 1985. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am. J. Med. 78: 737-741.
21. Martinez-Maza, O., E. Crabb, R. T. Mitsuyasu, J. L. Fahey,and J. V. Giorgi. 1987. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B-lymphocyte activation and immaturity. J. Clin. Immunol. 138:3720-3724.
22. Melmed, R. N., J. M. G.Taylor, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1989. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes and the development of AIDS. J. Acquired Immune Defic. Syndr. 2:70-76.
23. Miedema, F., M. Tersmette, and R. A. VanLier. 1990. AIDS pathogenesis: a dynamic interaction between HIV and the immune system. Immunol. Today 11:293-297.
24. Moss, A. R., S. Bacchetti, D. Osmond, W. Krampf, R. E. Chaisson, D. Stites, J. Wilber, J. P. Allain, and J. Carlson. 1988. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br. Med. J. 296:745-750.
25. Nishanian, P., B. Hofmann, Y. X. Wang, A. L. Jackson, R. Detels, and J. L. Fahey. 1991. Serum soluble CDS molecule is a marker of CD8 T cell activation in HIV-1 disease. AIDS 5:805-812.
26. Nishanian, P., K. R. Huskins, S. Stehn, R. Detels, and J. L. Fahey. 1990. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Infect. Dis. 162:21-28.
27. Prince, H. E., S. H. Kleinman, V. C. Maino, and A. L. Jackson. 1988. In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors: soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis. J. Clin. Immunol. 8:114-120.
28. Prince, H. E., S. Kleinman, C. Czaplicki, J. John, and A. E. Williams. 1990. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J. Acquired Immune Defic. Syndr. 3:525-530.
29. Rinaldo, C., X. L. Huang, P. Piazza, J. Armstrong, G. Rappocciolo, G. Pazin, D. McMahon, P. Gupta, Z. Fan, and Z. Zhang. 1991. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. J. Infect. Dis. 164:638-645.